Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
13.11. | Pharmacielo Ltd: Pharmacielo 9,007,200 warrants extended | 2 | Stockwatch | ||
05.11. | Pharmacielo Ltd: Pharmacielo to extend nine million warrants by one year | 2 | Stockwatch | ||
PHARMACIELO Aktie jetzt für 0€ handeln | |||||
05.11. | PharmaCielo Ltd.: PharmaCielo Announces Intention to Extend Expiry Date of Warrants | 304 | Newsfile | All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - November 5, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) ("PharmaCielo"... ► Artikel lesen | |
11.10. | Pharmacielo Ltd: Pharmacielo 5,979,496 shares for debt | 1 | Stockwatch | ||
08.10. | Pharmacielo Ltd: Pharmacielo appoints auditor, changes year-end | 152 | Stockwatch | ||
07.10. | PharmaCielo Ltd.: PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024 | 369 | Newsfile | All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - October 7, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo"... ► Artikel lesen | |
16.08. | Pharmacielo Ltd: Pharmacielo loses $2.57-million in Q2 2024 | 1 | Stockwatch | ||
16.08. | PharmaCielo GAAP EPS of -C$0.015, revenue of C$0.78M | 1 | Seeking Alpha | ||
16.08. | PharmaCielo Cannabis Co. Sees 390% YoY Revenue Jump As Losses Narrow In Q2 2024 | 1 | Benzinga.com | ||
16.08. | PharmaCielo Ltd.: PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2024 | 298 | Newsfile | All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 16, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo"... ► Artikel lesen | |
18.07. | Pharmacielo Ltd: Pharmacielo reinstated for trading | 1 | Stockwatch | ||
17.07. | Pharmacielo Ltd: Pharmacielo awaits TSX-V OK for share reinstatement | 1 | Stockwatch | ||
17.07. | PharmaCielo Ltd.: PharmaCielo Provides Update on Reinstatement for Trading | 386 | Newsfile | Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 17, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier... ► Artikel lesen | |
05.07. | PharmaCielo Cannabis Co. Narrows Net Loss By 31% YoY In Q1, CEO Says Cost Reduction Efforts Showing Results | 1 | Benzinga.com | ||
05.07. | PharmaCielo reports Q1 results | 1 | Seeking Alpha | ||
04.07. | Pharmacielo Ltd: Pharmacielo files 2023, Q1 2024 financials; CTO revoked | 1 | Stockwatch | ||
04.07. | PharmaCielo Ltd.: PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2023, and the First Quarter Ended March 31, 2024 | 442 | Newsfile | All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 4, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo"... ► Artikel lesen | |
19.06. | Pharmacielo Ltd: Pharmacielo moved to Tier 2 | 1 | Stockwatch | ||
08.05. | PharmaCielo Ltd.: PharmaCielo Announces Issuance of Failure to File Cease Trade Order | 132 | Newsfile | All amounts expressed in Canadian dollars unless otherwise notedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 8, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo"... ► Artikel lesen | |
10.04. | PharmaCielo Ltd.: PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors | 486 | Newsfile | The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product.Experienced investor... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 19,802 | +1,46 % | Rückschlag für Bayer: Wie reagiert der Konzern? | Bayer verzeichnet im dritten Quartal 2024 tiefrote Zahlen: Ein Nettoverlust von 4,2 Milliarden Euro und ein Umsatzrückgang von 3,6% belasten das Unternehmen. Gleichzeitig belasten Milliardenabschreibungen... ► Artikel lesen | |
AURORA CANNABIS | 4,186 | +0,58 % | Aurora Cannabis Inc (3): Aurora Cannabis releases new recreational products | ||
CANOPY GROWTH | 3,730 | -0,53 % | What's Happening With Canopy Growth: Is It Time To Buy? | ||
TILRAY BRANDS | 1,290 | -0,27 % | Tilray Brands Inc: Tilray, Montlake team release game-day gold lager | ||
INNOCAN PHARMA | 0,148 | -1,67 % | Breaking News: InnoCan Pharma erzielt 24 Mio. USD Umsatz… | ||
TAAT GLOBAL ALTERNATIVES | 0,115 | +4,07 % | XFRA 2TP0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
DERMAPHARM | 37,500 | 0,00 % | Dermapharm-Aktie: Ein Pharmawert mit Potenzial? | Dermapharm war einer der größten Profiteure der Corona-Pandemie. Mittlerweile ist es um die Aktie wieder deutlich ruhiger geworden und der Kurs fiel um knapp zwei Drittel seit dem damaligen Allzeithoch... ► Artikel lesen | |
CRONOS GROUP | 1,968 | -0,25 % | Cronos Group Inc. (CRON): A Bull Case Theory | ||
DOCMORRIS | 31,700 | 0,00 % | UBS stuft DocMorris auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für DocMorris mit einem Kursziel von 25 Franken auf "Sell" belassen. Analyst Olivier Calvet wertete am Montagabend turnusmäßig... ► Artikel lesen | |
SYNBIOTIC | 5,580 | +2,20 % | EQS-Adhoc: SYNBIOTIC SE: SynBiotic SE schließt Einbringungsvertrag über den Erwerb von 50,2 % der Anteile an der greensby UG (haftungsbeschränkt), Vettweiss, ab. | EQS-Ad-hoc: SYNBIOTIC SE / Schlagwort(e): Beteiligung/Unternehmensbeteiligung
SynBiotic SE schließt Einbringungsvertrag über den Erwerb von 50,2 % der Anteile an der greensby UG (haftungsbeschränkt)... ► Artikel lesen | |
TRANSCANNA | 0,017 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 02.07.2024 | The following instruments on XETRA do have their last trading day on 02.07.2024Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 02.07.2024ISIN NameGB00BMGRFP88 CITIUS RESOURCES LS-... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
ORGANIGRAM | 1,438 | -1,78 % | Organigram Reports Third Quarter Fiscal 2024 Results | TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the third quarter... ► Artikel lesen | |
CRESCO LABS | 1,056 | +0,76 % | Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results | Record quarterly operating cash flow of $49 million and year to date operating cashflow of $103 million, an increase of 66% from the prior year period
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)... ► Artikel lesen | |
GREEN THUMB INDUSTRIES | 8,565 | -0,81 % | Green Thumb Industries Inc: Green Thumb's Rise to open two stores Nov. 23 |